What is the treatment for Loeffler's syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Loeffler's Syndrome

The first-line treatment for Loeffler's syndrome is empirical therapy with albendazole 400 mg twice daily for 3 days, plus ivermectin 200 μg/kg once daily for 3 days during the prepatent period, with consideration of steroids in severe cases. 1

Definition and Etiology

  • Loeffler's syndrome results from larval migration through the lungs following acute helminth infection, most commonly involving nematodes such as Ascaris lumbricoides, hookworm (Ancylostoma duodenale/Necator americanus), and Strongyloides stercoralis 1
  • The syndrome typically occurs during the prepatent period (1-2 weeks after infection), when larvae migrate through the lungs 1

Clinical Presentation

  • Fever, urticaria, wheeze, dry cough, and rarely hemoptysis 1
  • Migratory pulmonary infiltrates may be seen on chest radiograph 1
  • Peripheral blood eosinophilia is a characteristic finding 2
  • Symptoms are typically self-limited but can be severe in some cases 3

Diagnostic Approach

  • Diagnosis is primarily clinical, as symptoms occur during the prepatent period when stool examinations may still be negative 1
  • Key diagnostic features include:
    • Respiratory symptoms (cough, wheeze)
    • Peripheral eosinophilia
    • Pulmonary infiltrates on imaging
    • Recent travel to or residence in endemic areas 1
  • Concentrated stool microscopy should be performed in all patients returning from the tropics with eosinophilia 1
  • In some cases, larvae may be seen in sputum (rare) or bronchoalveolar lavage 1

Treatment Recommendations

First-line Treatment

  • Where no specific organism is identified, empirical treatment with:
    • Mebendazole 100 mg twice daily for 3 days plus ivermectin 200 μg/kg once daily for 3 days 1
    • Alternatively, single dose ivermectin 200 μg/kg and albendazole 400 mg can be used 1

Organism-Specific Treatment

  1. For Ascaris lumbricoides:

    • Albendazole 400 mg as a single dose 4, 5
    • Alternative: Mebendazole 500 mg as a single dose 4
  2. For Hookworm infection:

    • Albendazole 400 mg as a single dose 1
    • Alternative: Mebendazole 500 mg as a single dose 1
  3. For Strongyloides stercoralis:

    • Ivermectin 200 μg/kg once daily for 1-2 days 2
    • For immunocompromised patients: Ivermectin 200 μg/kg on days 1,2,15, and 16 1

Adjunctive Therapy

  • For severe symptoms, particularly with significant respiratory distress:
    • Prednisolone 30 mg daily for 5 days may reduce the duration of symptoms (expert opinion) 1
    • Caution is advised when using steroids in cases of suspected strongyloidiasis, as they may precipitate hyperinfection syndrome 1
  • Symptomatic treatment with bronchodilators (e.g., levosalbutamol) may be beneficial for wheezing 6

Follow-up and Monitoring

  • Consider retreatment 1 month after the resolution of pulmonary symptoms to ensure adult worms are treated (expert opinion) 1
  • Complete resolution of pulmonary pathology should be confirmed with follow-up chest imaging 6, 3

Special Considerations

  • Caution with steroids: Use with extreme caution if strongyloidiasis is suspected, as steroids may precipitate hyperinfection syndrome 1
  • Pregnancy/lactation: Consult specialist advice for treatment during pregnancy or lactation 1
  • Immunocompromised patients: These patients require more aggressive treatment and monitoring, particularly for strongyloidiasis 1

Prevention

  • Preventive measures include:
    • Proper hand hygiene
    • Avoiding walking barefoot in endemic areas
    • Proper food handling and cooking practices 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Ascaris Lumbricoides Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Intestinal Worms in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.